慢性粒细胞白血病

P53基因失活与慢性粒细胞白血病的急变、病情进展密切相关。

The inactivation of P53 is associated with the acute transformation phase and development of CML .

慢性粒细胞白血病患者胸腺输出功能与bcr-AblmRNA水平的关系

Relationship Between Thymus Output Function in CML Patients and Their bcr-abl mRNA Levels

Ph染色体阳性慢性粒细胞白血病患者多因素预后分析

Multivariate analysis of prognostic factors in Philadelphia chromosome-positive chronic granulocytic leukemia

慢性粒细胞白血病变异ph易位

Studies on variant pH translocations of chronic myelogenous leukemia

检测慢性粒细胞白血病相关基因的DNA电化学探针筛选实验研究

Screening Experimental Studies of DNA Electrochemical Probes for Detection of Relative Genes in Chronic Myelogenous Leukemia

Ph阳性慢性粒细胞白血病断裂点簇区域重排的探讨

Bcr Rearrangements in Ph Positive Chronic Myelocytic Leukemia

SHIP基因在慢性粒细胞白血病发病中的作用及机制探讨

The Investigation of the Expression and the Function of SHIP Gene in the Chronic Myelogenous Leukemia

两例Ph染色体阳性慢性粒细胞白血病患者具有少见型bcr/abl融合基因

Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr / abl fusion gene

慢性粒细胞白血病来源的DC细胞体外诱导高效而特异的抗肿瘤免疫

Study on the antitumor immune effect induced by dendritic cells derived from chronic myeloid leukemia

伊马替尼治疗Ph阳性慢性粒细胞白血病引起的骨髓形态学变化

Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia

FISH法动态观察慢性粒细胞白血病移植治疗后早期Ph阳性细胞

Dynamic monitering of Ph positive cells during early post-transplant period in chronic granulocytic leukemia by interphase FISH

bcr/AblmRNA反义寡核苷酸对慢性粒细胞白血病Ph~+细胞的作用

Effects of bcr / abl mRNA Antisense Oligonucleotides on Ph Positive Chronic Myelogenous Leukemia Cells

慢性粒细胞白血病p53基因功能检测

Functional detection of the p53 gene in chronic myeloid leukemia

RNA干扰对慢性粒细胞白血病bcr/abl融合基因表达的抑制作用

Inhibitory effect of RNA interference on chronic myeloid leukemia bcr / abl oncogene expression

格列卫对慢性粒细胞白血病Ph染色体和bcr/abl基因表达的影响

The Effect of Imatinib Mesylate Therapy on Ph Chromosome and Bcr / abl Gene Expression in Patients with CML

Ph阳性慢性粒细胞白血病患者伊马替尼治疗后的Ph阴性异常克隆演变

Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

PCR方法检测慢性粒细胞白血病bcr/AblmRNA

Examination of 32 patients with chronic myeloid leukemia for bcr / abl fusion mRNA using PCR assay

筑巢式RT-PCR检测慢性粒细胞白血病残留细胞

Residual cells detection in chronic myelocytic leukemia with RT-PCR

变异型Ph易位慢性粒细胞白血病der（9）缺失的FISH研究

FISH studies of deletion of derivative chromosome 9 in chronic myeloid leukemia patients with variant philadelphia translocations

荧光定量PCR对伊马替尼治疗后慢性粒细胞白血病bcr/abl融合基因变化的检测效果研究

Assessment of bcr / abl expression by real-time quantitative PCR in chronic myeloid leukemia patients after imatinib mesylate treatment

PCNA与慢性粒细胞白血病急变关系的研究

Study of PCNA and chronic granulocytic leukemia in blastic crisis

慢性粒细胞白血病患者Ph染色体变异易位的细胞遗传学特征与荧光原位杂交研究

Analysis and Identification of Variant Ph Chromosome Translocation in Patients with Chronic Myelogenous Leukemia by Conventional Cytogenetics and Fluorescence in situ Hybridization

IFN治疗慢性粒细胞白血病已为接受。

IFN has been extensively used as a myelosuppressive agent in chronic myeloid leukaemia .

实时定量RT-PCR监测慢性粒细胞白血病患者伊马替尼治疗过程中bcr/AblmRNA水平

Monitoring bcr / abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR

2-氨基甾体对慢性粒细胞白血病细胞系K562细胞增殖的抑制作用

Inhibitory effect of a novel 2-aminosteroid on the proliferation of K562 leukemia cells

应用COX模型判断慢性粒细胞白血病的预后

Judgement of Prognosis of Chronic Myelogenous LeuKemia with COX Model

甲磺酸伊马替尼是一种蛋白质酪氨酸激酶抑制剂，用于治疗Ph染色体阳性慢性粒细胞白血病和恶性胃肠道间质肿瘤。

Imatinib mesilate is a protein-tyrosine kinase inhibitor approved for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia and malignant gastrointestinal stromal tumors .

bcl-2基因表达在慢性粒细胞白血病急变中的意义

Expression of bcl 2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication

As2O3联合格列卫对难治性慢性粒细胞白血病的靶向治疗

The Clinic Study of Targeted Therapy in the Refractory Chronic Myelocytic Leukemia by As_2O_3 Combined with Imatinib Mesylate

HLA相合同胞供者异基因造血干细胞移植治疗慢性粒细胞白血病40例

HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia in 40 cases